SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is drawing attention after a recent rebound that traders say held its gains, with bullish technical setups and positioning ahead of earnings. The upbeat view contrasts with concerns that high rates and a sluggish housing market could continue to weigh on renovation demand.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sharp rally to fresh multi-year highs is drawing attention, with traders citing rotation into defensive, dividend-paying pharma stocks and positioning ahead of the quarterly report. Bulls see a technical breakout and pipeline momentum, while skeptics warn the move may meet resistance and point to patent-expiration and growth concerns.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,397.34014094 USD and is up 0.28 over the last 24 hours. It is currently trading on 12773 active market(s) with $12,152,377,915.37 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is drawing attention amid concerns over Binances reported major hack and paused withdrawals, with traders debating whether damaged exchange trust could trigger further selling. Others argue the market is absorbing the shock and point to Binances reported reimbursement progress and planned withdrawal reopening as reasons for optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on expected Q3 results and the Phase 3 QUILT-2.005 topline for ANKTIVA plus BCG in BCG-naive bladder cancer; the trial is database-locked, with a supplemental filing planned if results support it. Bullish traders see the readout and ANKTIVAs expanded bladder-cancer label as growth catalysts, while others question commercial uptake and point to competition, short-selling, and broader market weakness to explain the volatility.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders use the leveraged inverse Nasdaq ETF to hedge or bet on further weakness in tech, citing concerns about AI spending and valuations alongside recent tech-led selling. The community is divided: some expect more downside, while others warn that rumors of a U.S.Iran deal and a possible market rebound could reverse gains in the short ETF.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow is being discussed amid volatile, uneven trading across major indexes, with traders watching Fed policy and rising Treasury yields as pressures on equities. Some see relative strength in the Dow as money rotates away from tech, while others warn that inflation, oil-market risks and weakening momentum could deepen a selloff.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts upcoming quarterly results and whether continued ORLADEYO growth can support the stock despite its weak performance. Traders are also looking ahead to Navenibart and Netherton data, while debating managements acquisition strategy and expressing frustration over dilution and limited shareholder returns; buyout talk remains speculative.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results and outlook are drawing attention, with traders highlighting stronger streaming profitability and resilient theme-park performance. The reaction is mixed: some see support for a turnaround, while others point to the stocks persistent range-bound price action and difficulty holding gains.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its upcoming earnings report, with traders watching whether guidance holds and how management addresses pressure on the pharmacy benefit management business. Some see the recent pullback as a potential technical rebound setup, while others remain cautious after the stocks recent selling.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has lifted UVIX, drawing traders seeking a hedge against a broader market pullback. The community is split between expecting volatility to persistciting concerns about oil, interest rates and geopolitical risksand warning that UVIX can quickly lose value as volatility fades and its leveraged futures exposure decays.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Flexsteel Industries (FLXS) Misses Q1 Earnings Estimates

Flexsteel (FLXS) delivered earnings and revenue surprises of -0.80% and +0.68%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Consumer Insights Shape La-Z-Boy's Latest Innovations, Including The New PowerLift Chair Collection And AudioLuxe

Consumer Insights Shape La-Z-Boy's Latest Innovations, Including The New PowerLift Chair Collection And AudioLuxe Consumer Insights Shape La-Z-Boy's Latest Innovations, Including The New PowerLift Chair Collection And AudioLuxePR NewswireMONROE, Mich., Oct. 21, 2026 Key Highlights:Consumer insights...

La-Z-Boy Incorporated Announces Additional New Store Openings And Acquisitions

La-Z-Boy Incorporated Announces Additional New Store Openings And Acquisitions La-Z-Boy Incorporated Announces Additional New Store Openings And AcquisitionsPR NewswireMONROE, Mich., Oct. 15, 2026Key Highlights:La-Z-Boy Incorporated announces the successful completion of its acquisition of two...

LZB Investors with $100,000 in Losses Have Opportunity to Join La-Z-Boy Incorporated Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of La-Z-Boy Incorporated (La-Z-Boy or the Company) (NYSE: LZB) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses...

Do Options Traders Know Something About La-Z-Boy Stock We Don't?

Investors need to pay close attention to LZB stock based on the movements in the options market lately. 

La-Z-Boy President Sells 5,000 Shares

Key PointsThe transaction on Sept. 10, 2026, totaled $154,250 based on the weighted average execution price...

Interactive Brokers highlighted as Zacks Bull and La-Z-Boy Bear of the Day

Bear of the Day: La-Z-Boy (LZB)

An overall soft top line trend over recent years has led to weak share performance, with shares plunging following its latest set of results on softer-than-expected sales guidance. 

La-Z-Boy (LZB) Q1 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Relative Strength Alert For La-Z-Boy

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive...

La-Z-Boy, Inc. engages in the production, manufacturing, and distribution of residential furniture. It operates through the following business segments: Wholesale, Retail, and Corporate and Other. The Wholesale segment manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, ottomans and sleeper sofas, and imports case goods furniture, such as occasional pieces, bedroom sets, dining room sets, and entertainment centers. The Retail segment sells upholstered furniture, in addition to some case goods and other accessories to the end consumer through its company-owned La-Z-Boy Furniture Galleries stores. The Corporate and Other segment includes the shared costs for corporate functions, including human resources, information technology, finance, and legal. The company was founded by Edwards M. Knabusch and Edwin J. Shoemaker in 1927 and is headquartered in Monroe, MI.

La-Z-Boy Inc.

La-Z-Boy Stock Pops After-Hours On Q2 Beat, Dividend Hike And Restructuring: Retail Mood Still Cautious

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>La-Z-Boy reported revenue and profit above Wall Street’s targets, boosted by new stores.</li><li>Shares gained 7.5% in the after-market session.</li><li>The company also raised its quarterly dividend by 10%, and guided Q3 sales slightly above expectations.</li></ul>La-Z-Boy Inc.’s shares gained 7.5% in the after-market session on Tuesday, following the recliner and sofa company’s upbeat results.Revenue grew 0.3% to $522.5 million in the second quarter, topping analyst estimates of $517.6 million. Sales were largely driven by new stores, with retail sales growing 4%.Same-store sales, which strip out the effect of newly opened or acquired locations, fell 2%. The company acknowledged that the broader consumer and macroeconomic backdrop remains challenging. Adjusted&nbsp;earnings per share (EPS) were $0.71, handily beating&nbsp;Wall Street’s&nbsp;estimate of $0.54.“We are investing in the business for the long term, as highlighted by the opening of 15 new company-owned stores in the last 12 months and the advancement of our distribution and home delivery transformation project,” CEO and Board Chair Melinda Whittington said in a statement.<h2 class="st-heading-2">Retail’s View Neutral</h2>On Stokctwits, the retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/LZB">LZB</a> shifted to ‘neutral’ as of late Tuesday from ‘extremely bearish’ the prior day, with ‘extremely high’ message volume. User comments were mixed.<figure class="image"><img style="aspect-ratio:640/75;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_19_at_7_41_27_AM_png_cc0b52c46e.webp" alt="Screenshot 2025-11-19 at 7.41.27 AM.png" width="640" height="75"><figcaption>LZB sentiment and message volume as of November 18 | Source: Stocktwits</figcaption></figure>“Don’t expect this pop to last tbf,” said one user.&nbsp;<stembedurl>https://stocktwits.com/sloshy665/message/636659903</stembedurl>“$LZB closed it out for a sweet gain, enough to pay for a new recliner.&nbsp; Nice overnight trade,” said a user, with another saying the stock should be at least $40.<stembedurl>https://stocktwits.com/HankofTroy/message/636671135</stembedurl>LZB had closed at $29.59 on Tuesday, and has declined 32% so far this year.<h2 class="st-heading-2">Growth Initiatives</h2>La-Z-Boy said it is exiting certain non-core businesses, such as Kincaid and American Drew casegoods and Kincaid upholstery, and has made changes to the top management and workforce. Those initiatives will be substantially completed by the end of the fiscal year and will reduce sales by about $30 million while boosting margins, the company said.Unlike many peers, roughly 90% of La-Z-Boy’s finished goods are produced in the United States, leaving the company largely unaffected by U.S. tariff policy. In fact, the company said it is considering closing its UK manufacturing facility.La-Z-Boy bumped its quarterly dividend by 10% to just over $0.24 a share (payable on Dec. 15), and guided third-quarter sales that were marginally above analysts’ expectations.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Recliners on display at a La-Z-Boy store in La Mesa, California. (Photo by Jerod Harris/WireImage)

The recliner maker reported revenue and profit above Wall Street’s targets, boosted by new stores.

Why Did La-Z-Boy Stock Surge Over 7% After-Hours Today?

The recliner maker reported revenue and profit above Wall Street’s targets, boosted by new stores.


Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$30.44
Prev Close	$30.43
Open	$30.60
Dividend Yield	2.61%
50-Day Moving Average	$30.47
Beta	0.84
Avg. Volume	811,489.84
PE Ratio	15.41

52-Week High	$44.90
52-Week Low	$28.39
Market Capitalization	$1.22B
EPS (Annual)	$2.47
Price to Book	1.20
Revenue Per Employee	$208,493.63

Feed

News

Sentiment

Earnings

Fundamentals

Info

LZB Fundamentals